Disposition of 9584 shares by Marvin White of Aptevo Therapeutics subject to Rule 16b-3
| ER4 Stock | EUR 9.49 0.01 0.11% |
About 54% of EMERGENT BIOSOLUT's investor base is interested to short. The analysis of current outlook of investing in EMERGENT BIOSOLUT suggests that many traders are impartial regarding EMERGENT BIOSOLUT's prospects. The current market sentiment, together with EMERGENT BIOSOLUT's historical and current headlines, can help investors time the market. In addition, many technical investors use EMERGENT BIOSOLUT stock news signals to limit their universe of possible portfolio assets.
EMERGENT BIOSOLUT stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of EMERGENT daily returns and investor perception about the current price of EMERGENT BIOSOLUT as well as its diversification or hedging effects on your existing portfolios.
EMERGENT |
Filed transaction by Aptevo Therapeutics Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
EMERGENT BIOSOLUT Fundamental Analysis
We analyze EMERGENT BIOSOLUT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EMERGENT BIOSOLUT using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EMERGENT BIOSOLUT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
EMERGENT BIOSOLUT is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
EMERGENT BIOSOLUT Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EMERGENT BIOSOLUT stock to make a market-neutral strategy. Peer analysis of EMERGENT BIOSOLUT could also be used in its relative valuation, which is a method of valuing EMERGENT BIOSOLUT by comparing valuation metrics with similar companies.
Peers
EMERGENT BIOSOLUT Related Equities
| AF4 | Hanover Insurance | 2.60 | ||||
| 63TA | Tencent Music | 1.92 | ||||
| PL0 | Playa Hotels | 1.10 | ||||
| 9DB | Dave Busters | 0.56 | ||||
| PWT | TFS FINANCIAL | 0.75 | ||||
| YT2A | ATRESMEDIA | 1.54 |
Complementary Tools for EMERGENT Stock analysis
When running EMERGENT BIOSOLUT's price analysis, check to measure EMERGENT BIOSOLUT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMERGENT BIOSOLUT is operating at the current time. Most of EMERGENT BIOSOLUT's value examination focuses on studying past and present price action to predict the probability of EMERGENT BIOSOLUT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMERGENT BIOSOLUT's price. Additionally, you may evaluate how the addition of EMERGENT BIOSOLUT to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |